0->Your task is determining support relationships between individual sections of Clinical Trial Reports (CTRs) and clinical statements. CTRs detail the methodology and findings of clinical trials, assessing effectiveness and safety of new treatments. CTRs consist of 4 sections: (1) ELIGIBILITY CRITERIA listing conditions for patient participation, (2) INTERVENTION description specifying type, dosage, frequency, and duration of treatments, (3) RESULTS summary detailing participants, outcome measures, units, and conclusions, and (4) ADVERSE EVENTS listing signs and symptoms observed. Statements make claims about information in these sections, either for a single CTR or comparing two.
----------
1->

Evaluate Clinical Trial Reports (CTRs) to determine the efficacy and safety profiles of novel therapeutics. Dissect CTRs into four principal elements: ELIGIBILITY CRITERIA (patient inclusion conditions), INTERVENTION (treatment type, dosage, frequency, and duration), RESULTS (participant details, outcome measures, units, and conclusions), and ADVERSE EVENTS (observed signs and symptoms). Validate clinical assertions pertaining to individual CTRs or comparative analyses.
----------
2->

Examine Clinical Trial Reports (CTRs) to evaluate the efficacy and safety profiles of novel therapeutic interventions. Break down CTRs into four principal components: (1) INCLUSION CRITERIA, specifying patient eligibility conditions, (2) THERAPEUTIC INTERVENTION, detailing treatment specifics such as type, dosage, administration frequency, and treatment length, (3) PARTICIPANT OUTCOMES, summarizing participant data, outcome metrics, units of measurement, and findings, and (4) POTENTIAL ADVERSE EVENTS, documenting any detected signs and symptoms. Analyze clinical assertions that either validate a single CTR or contrast two.
----------
3->

Perform a detailed examination of Clinical Trial Reports (CTRs), focusing on discerning and explicating the interrelationships between distinct segments and clinical assertions. CTRs are comprised of four principal components: (1) ELIGIBILITY CRITERIA, specifying patient inclusion conditions, (2) INTERVENTION, describing treatment particulars including type, dosage, administration frequency, and treatment length, (3) RESULTS, encapsulating participant data, outcome metrics, units of measurement, and derived conclusions, and (4) ADVERSE EVENTS, registering any observed signs and symptoms. Ensure that statements precisely mirror and juxtapose data across these components within a single CTR or across various CTRs.
----------
4->

Analyze Clinical Trial Reports (CTRs) to assess the effectiveness and safety of new treatments. Break down CTRs into four key components: ELIGIBILITY CRITERIA (patient inclusion conditions), INTERVENTION (treatment type, dosage, frequency, and duration), RESULTS (participant details, outcome measures, units, and conclusions), and ADVERSE EVENTS (observed signs and symptoms). Examine and substantiate clinical claims related to individual CTRs or comparative analyses.
----------
